Grinspoon SK, Watanabe M, Ribaudo HJ, Bloomfield GS, Fichtenbaum CJ, Umbleja T, Chu SM, Fitch KV, Diggs MR, Zhao S, Looby SE, Currier JS, Aberg JA, Malvestutto CD, Erlandson KM, Martinez E, Asupoto O, Gupta SK, Lopez-Bernaldo de Quiros JC, Nixon D, Bedimo R, Lu MT, Douglas PS, Zanni MV. Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV. Clin Infect Dis. 2026 Feb 04; 81(6):e548-e557.

Corley MJ, Watanabe M, Pang APS, Dwaraka VB, Smith R, Samaneka W, Henn S, Munsiff S, Saumoy M, McCallum S, Fitch KV, Chu SM, Diggs MR, Aberg JA, Malvestutto CD, Fichtenbaum CJ, Currier JS, Zanni MV, Douglas PS, Lu MT, Landay AL, Erlandson KM, Ribaudo HJ, Grinspoon SK. Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial. Clin Infect Dis. 2026 Feb 04; 81(6):e560-e567.

McGill LS, Clay OJ, Edwards KA, Jones KF, Long DM, Johnson MO, Bair MJ, Browne LE, Liebschutz JM, Demonte W, Agil D, Burkholder G, Durr AL, Farel CE, Johnson B, Orris SM, Napravnik S, Thomas T, Merlin JS. Trajectories of Pain Impact and Pain Self-Efficacy in People With HIV and Chronic Pain: Extending Findings From the Skills TO Manage Pain Randomized Clinical Trial. J Acquir Immune Defic Syndr. 2025 Dec 01; 100(4):347-354.

Rogg L, Underwood M, Hanan N, Castillo-Mancilla JR, Kahl L, Halliday F, Ghita GL, Jeffrey JL, Byrne S, Onodera T, Horton J, Gartland M. Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clin Infect Dis. 2025 Oct 06; 81(3):510-520.

Hawkins KL, Dandachi D, Verzani Z, Brannock MD, Lewis C, Abedian S, Jaferian S, Wuller S, Truong J, Witvliet MG, Dymond G, Mehta HB, Patel PB, Hill E, Weiner MG, Carton TW, Kaushal R, Feuerriegel E, Tran HG, Marks K, Oliveira CR, Gardner EM, Ofotokun I, Gulick RM, Erlandson KM. HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record-Based Cohort Study. Clin Infect Dis. 2025 Oct 06; 81(3):427-438.

Engel N, Sykes C, Schauer AP, Kashuba ADM, Anderson PL, Bushman LR, Cottrell ML. Interlaboratory comparison of a dried blood spot assay for antiretroviral adherence: implications for clinical application. J Antimicrob Chemother. 2025 Oct 03; 80(10):2727-2731.

Edwards KA, Long D, Jones KF, Durr AL, Farel CE, Liebschutz JM, Bair MJ, Agil D, Napravnik S, Browne L, Johnson B, Thomas T, Burkholder G, Clay OJ, Demonte W, Orris SM, Johnson MO, Merlin J. The Skills to Manage Pain Randomized Trial: Results of Antiretroviral Therapy Adherence, HIV Primary Care Retention, and Virologic Suppression Outcomes. J Acquir Immune Defic Syndr. 2025 Oct 01; 100(2):180-185.

Anderson PL, Coppinger C, Cottrell ML, Marzinke MA. Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment. J Acquir Immune Defic Syndr. 2025 Oct 01; 100(2):162-169.

Mugwanya KK, Saina M, Mugo NR, MaWhinney S, Morrow M, Schaafsma TT, Donnell D, Glidden DV, Ngure K, Brown CE, Rechkina EA, Chohan BH, Wu L, Hill E, Koome E, Akelo N, Mbaire S, Morrison SA, Kibatha M, Njeru I, Muriithi M, Coppinger C, Bushman L, Baeten JM, Anderson PL. Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study. PLoS Med. 2025 Sep; 22(9):e1004732.

Westergaard RP, Ballard HK, Gicquelais RE, Firnhaber C, Miller R, Wolman M, Liebert C, Steeley E, Mundt MP, Park LS, Quanbeck A. Health System-Level Implementation of Digital Health Support for People Living With HIV and Substance Use Disorders: Protocol for a Cluster-Randomized, Stepped-Wedge Clinical Trial. JMIR Res Protoc. 2025 Aug 29; 14:e69842.